Sorrento Therapeutics Inc (NASDAQ:SRNE)

6.55
Delayed Data
As of Jun 22
 +0.40 / +6.50%
Today’s Change
1.50
Today|||52-Week Range
10.65
+72.37%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Sorrento Therapeutics Inc have a median target of 25.00, with a high estimate of 40.00 and a low estimate of 10.00. The median estimate represents a +281.68% increase from the last price of 6.55.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Sorrento Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$5.1M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 51.32%
 
 
 
 
 
 
Growthannually -811.54%
 
 
 
 
 
 

Sales

Growthquarterly -18.05%
 
 
 
 
 
 
Growthannually -88.55%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.